Antibiotic Prophylaxis of Transrectal Biopsy of the Prostate: A Plea for Fosfomycin
The complication rate was 1.1%, and FOS single dose therefore represents sufficient AP for TRBP in this collective. FOS as a single dose should be reevaluated in a prospective study to obtain approval in Germany for this indication.
Authors
- Marco J. Schnabel (ORCID: https://orcid.org/0000-0002-1535-2952)
- Wolfgang Otto (ORCID: https://orcid.org/0000-0003-0523-5442)
- Philipp Spachmann (ORCID: https://orcid.org/0000-0003-0183-2952)
- Johannes Breyer (ORCID: https://orcid.org/0000-0003-0674-4150)
- Daniel R. Witt (ORCID: https://orcid.org/0000-0002-9770-8042)
- Stefan Denzinger
- Daniel Vergho
- Maximilian Burger (ORCID: https://orcid.org/0009-0005-5013-9435)
Institutions
- Caritas-Krankenhaus St. Josef (DE)
- Platte Consult (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- Urologia Internationalis
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1159/000541798
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00